Reports
Global Humanised Mouse and Rat Model Market Size, Forecast: By Type: Humanised Mouse Models, Humanised Rat Models; By Application: Oncology, Immunology and Infectious Diseases, Neuroscience, Haematopoiesis, Toxicology, Others; By End Use; Regional Analysis; Competitive Landscape; 2024-2032
Global Humanised Mouse and Rat Model Market Outlook
The global humanised mouse and rat model market reached a value of more than USD 105.9 million in 2021. The industry is further expected to grow at a CAGR of about 10.15% in the forecast period of 2024-2032 to reach a value of over USD 189.10 million by 2027.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America and the Asia pacific to Significantly Aid the Humanised Mouse and Rat Model Industry
North America represents one of the leading regions in the global market for humanised mouse and rat model. This can be attributed to growing biomedical research, preclinical activities by CROs and pharmaceutical research and development, continued and responsible use of animals ensured by animal care organisations, increasing monoclonal antibody production in the United States. This, along with the growing stem cell research, and government support and initiatives for the development of protein drugs in Canada, is contributing to the market growth. Additionally, the growing number of investments by the government for the development of innovations in mouse models is spurring market growth. In addition to this, the rising focus by leading market players on market development strategies is positively influencing the growth of the regional market.
Meanwhile, the Asia Pacific region, too, occupies a considerable share in the market due to international alliances for research and development activities in China, initiatives to reduce drug approval time, mandatory animal testing for all pharmaceutical drugs and cosmetics in China, increasing government and private sector investments in life sciences sector, growing consumer demand, and growing biomedical and medical research. In addition to this, research in regenerative medicine in Japan, and the overall flourishing healthcare system of Japan is propelling the growth in the Asia Pacific region. Furthermore, the growth of the biomedical industry in India, development of bio-clusters to boost India’s biotechnology, growth in translational and biomedical research in different countries of the Asia Pacific region is expanding the growth of the market. These trends are likely to continue in the forecast period as well and contribute to the market growth.
Humanised Mouse and Rat Model: Market Segmentation
In biology and medical research, a humanised mouse and rat model is a model that comprises functional human genes, cells, tissues, and organs. These mouse and rat models are utilised to simulate a human immune system in both healthy and diseased situations.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
By type, the market is divided into:
- Humanised Mouse Models
- Cell-based Humanised Mouse Model
- CD34
- PBMC
- BLT
- Genetic Humanised Mouse Model
- Cell-based Humanised Mouse Model
- Humanised Rat Models
The market based on application, can be classified into:
- Oncology
- Immunology and Infectious Diseases
- Neuroscience
- Haematopoiesis
- Toxicology
- Others
Based on end use, the market can be categorised into:
- Pharmaceutical and Biotechnology Companies
- Contract Research Organisations
- Academic and Research Institutions
The EMR report looks into the regional markets for humanised mouse and rat model like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Rising Demand for Personalised Medicine Boosting the Market Growth
Due to the growing demand for personalised medication, the market for humanised mouse and rat model is likely to grow at a significant pace during the forecast period, as these medicines are designed using animal models, particularly mice models. In order to determine the most appropriate therapy, the model is treated with a variety of medications or gene therapies, resulting in personalised medication for patients, thereby propelling the market growth. The growth of the market can further be determined by the increasing number of research activities involving humanised models, in pharmaceutical and biotechnology companies, technological developments, use of mouse and rat models for the detection of immunodeficiency disorders, tumours, and other unusual diseases.
Furthermore, the market is expected to be aided by rising applications of the model in cancer research activities, and increasing innovation to develop humanised mouse models tailored to meet the specific needs of cancer research. The growth of humanised mouse model industry can also be attributed to the rising incidences of chronic disorders and growing demand for efficient therapeutic drugs, which is anticipated to bring new opportunities. As a result, the rapidly flourishing medical industry around the world is boosting the market growth of humanised mouse and rat model.
Key Industry Players in the Global Humanised Mouse and Rat Model Market
The report gives a detailed analysis of the following key players in the global humanised mouse and rat model market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- The Jackson Laboratory
- GenOway S.A.
- TransGenic Inc.
- Horizon Discovery Group plc
- Vitalstar Biotechnology Co., Ltd.
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2023 |
| Historical Period | 2018-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Type, Application, End Use, Region |
| Breakup by Type | Humanised Mouse Models, Humanised Rat Models |
| Breakup by Application | Oncology, Immunology and Infectious Diseases, Neuroscience, Haematopoiesis, Toxicology, Others |
| Breakup by End Use | Pharmaceutical and Biotechnology Companies, Contract Research Organisations, Academic and Research Institutions |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | The Jackson Laboratory, GenOway S.A., TransGenic Inc., Horizon Discovery Group plc, Vitalstar Biotechnology Co., Ltd., Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Humanised Mouse and Rat Model Market Analysis
8.1 Key Industry Highlights
8.2 Global Humanised Mouse and Rat Model Historical Market (2018-2023)
8.3 Global Humanised Mouse and Rat Model Market Forecast (2024-2032)
8.4 Global Humanised Mouse and Rat Model Market by Type
8.4.1 Humanised Mouse Models
8.4.1.1 Historical Trend (2018-2023)
8.4.1.2 Forecast Trend (2024-2032)
8.4.1.2.1 Cell-based Humanised Mouse Model
8.4.1.2.1.1 CD34
8.4.1.2.1.2 PBMC
8.4.1.2.1.3 BLT
8.4.1.2.2 Genetic Humanised Mouse Model
8.4.2 Humanised Rat Models
8.4.2.1 Historical Trend (2018-2023)
8.4.2.2 Forecast Trend (2024-2032)
8.5 Global Humanised Mouse and Rat Model Market by Application
8.5.1 Oncology
8.5.1.1 Historical Trend (2018-2023)
8.5.1.2 Forecast Trend (2024-2032)
8.5.2 Immunology and Infectious Diseases
8.5.2.1 Historical Trend (2018-2023)
8.5.2.2 Forecast Trend (2024-2032)
8.5.3 Neuroscience
8.5.3.1 Historical Trend (2018-2023)
8.5.3.2 Forecast Trend (2024-2032)
8.5.4 Haematopoiesis
8.5.4.1 Historical Trend (2018-2023)
8.5.4.2 Forecast Trend (2024-2032)
8.5.5 Toxicology
8.5.5.1 Historical Trend (2018-2023)
8.5.5.2 Forecast Trend (2024-2032)
8.5.6 Others
8.6 Global Humanised Mouse and Rat Model Market by End Use
8.6.1 Pharmaceutical and Biotechnology Companies
8.6.1.1 Historical Trend (2018-2023)
8.6.1.2 Forecast Trend (2024-2032)
8.6.2 Contract Research Organisations
8.6.2.1 Historical Trend (2018-2023)
8.6.2.2 Forecast Trend (2024-2032)
8.6.3 Academic and Research Institutions
8.6.3.1 Historical Trend (2018-2023)
8.6.3.2 Forecast Trend (2024-2032)
8.7 Global Humanised Mouse and Rat Model Market by Region
8.7.1 North America
8.7.1.1 Historical Trend (2018-2023)
8.7.1.2 Forecast Trend (2024-2032)
8.7.2 Europe
8.7.2.1 Historical Trend (2018-2023)
8.7.2.2 Forecast Trend (2024-2032)
8.7.3 Asia Pacific
8.7.3.1 Historical Trend (2018-2023)
8.7.3.2 Forecast Trend (2024-2032)
8.7.4 Latin America
8.7.4.1 Historical Trend (2018-2023)
8.7.4.2 Forecast Trend (2024-2032)
8.7.5 Middle East and Africa
8.7.5.1 Historical Trend (2018-2023)
8.7.5.2 Forecast Trend (2024-2032)
9 North America Humanised Mouse and Rat Model Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.2 Canada
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
10 Europe Humanised Mouse and Rat Model Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2018-2023)
10.1.2 Forecast Trend (2024-2032)
10.2 Germany
10.2.1 Historical Trend (2018-2023)
10.2.2 Forecast Trend (2024-2032)
10.3 France
10.3.1 Historical Trend (2018-2023)
10.3.2 Forecast Trend (2024-2032)
10.4 Italy
10.4.1 Historical Trend (2018-2023)
10.4.2 Forecast Trend (2024-2032)
10.5 Others
11 Asia Pacific Humanised Mouse and Rat Model Market Analysis
11.1 China
11.1.1 Historical Trend (2018-2023)
11.1.2 Forecast Trend (2024-2032)
11.2 Japan
11.2.1 Historical Trend (2018-2023)
11.2.2 Forecast Trend (2024-2032)
11.3 India
11.3.1 Historical Trend (2018-2023)
11.3.2 Forecast Trend (2024-2032)
11.4 ASEAN
11.4.1 Historical Trend (2018-2023)
11.4.2 Forecast Trend (2024-2032)
11.5 Australia
11.5.2 Historical Trend (2018-2023)
11.5.2 Forecast Trend (2024-2032)
11.6 Others
12 Latin America Humanised Mouse and Rat Model Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2018-2023)
12.1.2 Forecast Trend (2024-2032)
12.2 Argentina
12.2.1 Historical Trend (2018-2023)
12.2.2 Forecast Trend (2024-2032)
12.3 Mexico
12.3.1 Historical Trend (2018-2023)
12.3.2 Forecast Trend (2024-2032)
12.4 Others
13 Middle East and Africa Humanised Mouse and Rat Model Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2018-2023)
13.1.2 Forecast Trend (2024-2032)
13.2 United Arab Emirates
13.2.1 Historical Trend (2018-2023)
13.2.2 Forecast Trend (2024-2032)
13.3 Nigeria
13.3.1 Historical Trend (2018-2023)
13.3.2 Forecast Trend (2024-2032)
13.4 South Africa
13.4.1 Historical Trend (2018-2023)
13.4.2 Forecast Trend (2024-2032)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Value Chain Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Company Profiles
16.2.1 The Jackson Laboratory
16.2.1.1 Company Overview
16.2.1.2 Product Portfolio
16.2.1.3 Demographic Reach and Achievements
16.2.1.4 Certifications
16.2.2 GenOway S.A.
16.2.2.1 Company Overview
16.2.2.2 Product Portfolio
16.2.2.3 Demographic Reach and Achievements
16.2.2.4 Certifications
16.2.3 TransGenic Inc.
16.2.3.1 Company Overview
16.2.3.2 Product Portfolio
16.2.3.3 Demographic Reach and Achievements
16.2.3.4 Certifications
16.2.4 Horizon Discovery Group plc
16.2.4.1 Company Overview
16.2.4.2 Product Portfolio
16.2.4.3 Demographic Reach and Achievements
16.2.4.4 Certifications
16.2.5 Vitalstar Biotechnology Co., Ltd.
16.2.5.1 Company Overview
16.2.5.2 Product Portfolio
16.2.5.3 Demographic Reach and Achievements
16.2.5.4 Certifications
16.2.6 Others
17 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Humanised Mouse and Rat Model Market: Key Industry Highlights, 2018 and 2032
2. Global Humanised Mouse and Rat Model Historical Market: Breakup by Type (USD Million), 2018-2023
3. Global Humanised Mouse and Rat Model Market Forecast: Breakup by Type (USD Million), 2024-2032
4. Global Humanised Mouse and Rat Model Historical Market: Breakup by Application (USD Million), 2018-2023
5. Global Humanised Mouse and Rat Model Market Forecast: Breakup by Application (USD Million), 2024-2032
6. Global Humanised Mouse and Rat Model Historical Market: Breakup by End Use (USD Million), 2018-2023
7. Global Humanised Mouse and Rat Model Market Forecast: Breakup by End Use (USD Million), 2024-2032
8. Global Humanised Mouse and Rat Model Historical Market: Breakup by Region (USD Million), 2018-2023
9. Global Humanised Mouse and Rat Model Market Forecast: Breakup by Region (USD Million), 2024-2032
10. North America Humanised Mouse and Rat Model Historical Market: Breakup by Country (USD Million), 2018-2023
11. North America Humanised Mouse and Rat Model Market Forecast: Breakup by Country (USD Million), 2024-2032
12. Europe Humanised Mouse and Rat Model Historical Market: Breakup by Country (USD Million), 2018-2023
13. Europe Humanised Mouse and Rat Model Market Forecast: Breakup by Country (USD Million), 2024-2032
14. Asia Pacific Humanised Mouse and Rat Model Historical Market: Breakup by Country (USD Million), 2018-2023
15. Asia Pacific Humanised Mouse and Rat Model Market Forecast: Breakup by Country (USD Million), 2024-2032
16. Latin America Humanised Mouse and Rat Model Historical Market: Breakup by Country (USD Million), 2018-2023
17. Latin America Humanised Mouse and Rat Model Market Forecast: Breakup by Country (USD Million), 2024-2032
18. Middle East and Africa Humanised Mouse and Rat Model Historical Market: Breakup by Country (USD Million), 2018-2023
19. Middle East and Africa Humanised Mouse and Rat Model Market Forecast: Breakup by Country (USD Million), 2024-2032
20. Global Humanised Mouse and Rat Model Market Structure
Key Questions Answered in the Report
In 2021, the global humanised mouse and rat model market attained a value of more than USD 105.9 million.
The market is projected to grow at a CAGR of 10.15% between 2024 and 2032.
The market is estimated to witness a healthy growth rate in the forecast period of 2024-2032 to reach over USD 189.10 million by 2027.
The market is being driven by advancements in personalised medications, heavy investments in the medical research and development, and the growing initiatives to reduce drug approval time.
The market growth can be determined by the use of humanised mouse and rat models for the detection of immunodeficiency disorders, tumours, and other unusual diseases.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The major types of humanised mouse and rat models are humanised mouse models and humanised rat models.
The leading applications of humansied mouse and rat models are oncology, immunology and infectious diseases, neuroscience, haematopoiesis, and toxicology, among others.
The significant end uses of humanised mouse and rat models are pharmaceutical and biotechnology companies, contract research organisations, and academic and research institutions.
The major players in the industry are The Jackson Laboratory, GenOway S.A., TransGenic Inc., Horizon Discovery Group plc, and Vitalstar Biotechnology Co., Ltd., among others.
Analyst Review
The global humanised mouse and rat model market attained a value of more than USD 105.9 million in 2021, driven by the growing demand for personalised medicine. Aided by the increasing number of research activities involving humanised models, the market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 10.15%. The market is projected to reach over USD 189.10 million by 2027.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on type, the market is divided into humanised mouse models and humanised rat models. The leading applications of humansied mouse and rat models are oncology, immunology and infectious diseases, neuroscience, haematopoiesis, and toxicology, among others. On the basis of end use, the market can be classified into pharmaceutical and biotechnology companies, contract research organisations, and academic and research institutions. The major regional markets for humanised mouse and rat model are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include The Jackson Laboratory, GenOway S.A., TransGenic Inc., Horizon Discovery Group plc, and Vitalstar Biotechnology Co., Ltd., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$2799
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER